(Q40823709)

24 September 2017

Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. (English)

1 reference

24 September 2017

Wallace PK

1

1 reference

24 September 2017

Tsang KY

2

1 reference

24 September 2017

Goldstein J

3

1 reference

24 September 2017

Correale P

4

1 reference

24 September 2017

Jarry TM

5

1 reference

24 September 2017

Schlom J

6

1 reference

24 September 2017

Guyre PM

7

1 reference

24 September 2017

Ernstoff MS

8

1 reference

24 September 2017

Fanger MW

9

1 reference

24 September 2017

1 February 2001

1 reference

Journal of Immunological Methods

24 September 2017

1 reference

24 September 2017

248

1 reference

24 September 2017

1-2

1 reference

24 September 2017

183-194

1 reference

TAP1-independent loading of class I molecules by exogenous viral proteins

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Processing and presentation of intact hen egg-white lysozyme by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

5-fluorouracil and allopurinol combined with recombinant interferon-alpha 2b in the treatment of patients with advanced prostate cancer: a phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Tumor-infiltrating lymphocytes from nonrenal urological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Fc gamma receptor-mediated phagocytosis requires tyrosine kinase activity and is ligand independent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

MHC class I presentation of live and heat-inactivated Sendai virus antigen in T2Kb cells depends on an intracellular compartment with endosomal characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Antigen presentation for T cell interleukin-2 secretion is a late acquisition of neonatal B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

A new foreign policy: MHC class I molecules monitor the outside world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Demonstration of a rational strategy for human prostate cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Adoptive immunotherapy using lymphokine-activated killer cells and recombinant interleukin-2 in preventing and treating spontaneous pulmonary metastases of syngeneic Dunning rat prostate tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Interleukin-6: a candidate mediator of human prostate cancer morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Fc gamma RI blockade and modulation for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Human tumor antigens recognized by T lymphocytes: implications for cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

10.1016/S0022-1759(00)00351-3

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference